A1 Refereed original research article in a scientific journal
Brain texture alterations predict subtle visual perceptual dysfunctions in recent onset psychosis and clinical high-risk state
Authors: Lencer, Rebekka; Sprenger, Andreas; Meyhöfer, Inga; Dannlowski, Udo; Romer, Georg; Kambeitz-Ilankovic, Lana; Kambeitz, Joseph; Lichtenstein, Theresa; Rosen, Marlene; Ruhrmann, Stephan; Haas, Shalaila S.; Salokangas, Raimo K. R.; Pantelis, Christos; Bonivento, Carolina; Schultze-Lutter, Frauke; Meisenzahl, Eva; Brambilla, Paolo; Bertolino, Alessandro; Upthegrove, Rachel; Davatzikos, Christos; Koutsouleris, Nikolaos; Borgwardt, Stefan; Andreou, Christina; Korda, Alexandra; PRONIA Consortium
Publisher: Springer Nature
Publication year: 2026
Journal: Translational Psychiatry
Article number: 113
Volume: 16
eISSN: 2158-3188
DOI: https://doi.org/10.1038/s41398-026-03840-x
Publication's open availability at the time of reporting: Open Access
Publication channel's open availability : Open Access publication channel
Web address : https://doi.org/10.1038/s41398-026-03840-x
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/515655371
Self-archived copy's licence: CC BY
Self-archived copy's version: Publisher`s PDF
Deeper understanding of Subtle Visual Dysfunctions (VisDys) in the early stage of mental illness and their neurobiological underpinnings, as reflected by microstructural brain texture features, could advance our understanding of the underlying disease perceptual mechanisms that mediate susceptibility to psychosis. In this study, we aim a) to investigate the utility of brain texture features for the prediction of VisDys in recent onset psychosis (ROP) and clinical high-risk syndromes for psychosis (CHR-P), respectively, b) to test prediction models established in ROP and CHR-P in an independent validation sample with recent onset depression (ROD) diagnoses and c) to test for symptom expression related brain features associated with VisDys. sMRI were acquired in a training sample including 128 ROP (67 patients with VisDys), 134 CHR-P (71 patients with VisDys). Independent validation sets included 46 ROP (19 with VisDys), 124 CHR-P (68 patients with VisDys) and a sample of 256 ROD (50 patients with VisDys). Both classification schemas in ROP and CHR-P presented balanced accuracy >77% and >64% in the independent validation samples of ROP, CHR-P, and ROD, respectively. Statistically significant associations were identified with scores from the Positive and Negative Symptom Scale, psychosocial functioning, and the Scale of Negative Symptoms.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
Open Access funding enabled and organized by Projekt DEAL.